GILEAD SCIENCES SL
- Country
- 🇪🇸Spain
- Ownership
- -
- Established
- 1994-01-01
- Employees
- -
- Market Cap
- $95.8B
Safety Study of Tecadenoson to Treat Atrial Fibrillation
- First Posted Date
- 2008-07-11
- Last Posted Date
- 2014-03-11
- Lead Sponsor
- Gilead Sciences
- Target Recruit Count
- 21
- Registration Number
- NCT00713401
- Locations
- 🇺🇸
CV Therapeutics, Inc., Palo Alto, California, United States
Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Patients With Cystic Fibrosis, Mild Lung Disease, and P. Aeruginosa
- Conditions
- Interventions
- First Posted Date
- 2008-07-09
- Last Posted Date
- 2010-12-20
- Lead Sponsor
- Gilead Sciences
- Target Recruit Count
- 160
- Registration Number
- NCT00712166
- Locations
- 🇺🇸
Children's Memorial Hospital, Chicago, Illinois, United States
🇺🇸Penn Presbyterian Medical Center, Philadelphia, Pennsylvania, United States
🇺🇸Drexel University College of Medicine, Pulmonary Associates, Philadelphia, Pennsylvania, United States
Dose Escalation Study of CAL-101 in Select Relapsed or Refractory Hematologic Malignancies
- Conditions
- Interventions
- First Posted Date
- 2008-07-04
- Last Posted Date
- 2012-08-31
- Lead Sponsor
- Gilead Sciences
- Target Recruit Count
- 192
- Registration Number
- NCT00710528
- Locations
- 🇺🇸
Sarah Cannon Research Institute, Nashville, Tennessee, United States
🇺🇸The Sidney Kimmel Comprehensive Cancer Center at John Hopkins, Baltimore, Maryland, United States
🇺🇸Weill Medical College of Cornell, New York, New York, United States
Multicenter, Randomized, Double-Blind, Double-Dummy, Phase 3 Study of the Safety and Efficacy of Elvitegravir Versus Raltegravir
- Conditions
- Interventions
- First Posted Date
- 2008-07-02
- Last Posted Date
- 2016-05-30
- Lead Sponsor
- Gilead Sciences
- Target Recruit Count
- 724
- Registration Number
- NCT00708162
- Locations
- 🇺🇸
Whitman-Walker Clinic, Washington, District of Columbia, United States
🇺🇸Orlando Immunology Center, Orlando, Florida, United States
🇺🇸Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States
CRITIC - Treatment of Candidemia and Invasive Candidiasis
- First Posted Date
- 2008-05-02
- Last Posted Date
- 2009-03-27
- Lead Sponsor
- Gilead Sciences
- Target Recruit Count
- 39
- Registration Number
- NCT00670657
- Locations
- 🇮🇹
Gilead Sciences Srl, Milan, Italy
Efficacy Study of CYT997 in Multiple Myeloma
- First Posted Date
- 2008-04-22
- Last Posted Date
- 2018-06-08
- Lead Sponsor
- Gilead Sciences
- Target Recruit Count
- 5
- Registration Number
- NCT00664378
- Locations
- 🇦🇺
The Alfred Hospital, Melbourne, Victoria, Australia
Efficacy Study of CYT997 in Combination With Carboplatin in Glioblastoma
- First Posted Date
- 2008-04-02
- Last Posted Date
- 2013-05-03
- Lead Sponsor
- Gilead Sciences
- Target Recruit Count
- 20
- Registration Number
- NCT00650949
- Locations
- 🇦🇺
Royal North Shore Hospital, St-Leonards, New South Wales, Australia
🇦🇺Flinders Medical Centre, Bedford Park, South Australia, Australia
🇦🇺Gold Coast Hospital, Southport, Queensland, Australia
Metabolic Impact Assessment of Tenofovir Disoproxil Fumarate on Non-HIV-1 Infected Healthy Adult Male Volunteers
- Conditions
- Interventions
- First Posted Date
- 2008-04-01
- Last Posted Date
- 2008-04-01
- Lead Sponsor
- Gilead Sciences
- Target Recruit Count
- 8
- Registration Number
- NCT00648817
- Locations
- 🇬🇧
Chelsea and Westminster Hospital, London, United Kingdom
Study to Evaluate Changes in Limb Fat When Switching From a Thymidine Analogue
- Conditions
- Interventions
- First Posted Date
- 2008-04-01
- Last Posted Date
- 2008-06-30
- Lead Sponsor
- Gilead Sciences
- Target Recruit Count
- 100
- Registration Number
- NCT00647946
- Locations
- 🇬🇧
Gilead Sciences, Abingdon, Cambridge, United Kingdom
CHARM: Chronic Hepatitis B Antihepadnaviral Resistance Mutation Study
- First Posted Date
- 2008-03-28
- Last Posted Date
- 2011-11-22
- Lead Sponsor
- Gilead Sciences
- Target Recruit Count
- 788
- Registration Number
- NCT00645736
- Locations
- 🇦🇺
Gilead Sciences Pty Ltd, East Melbourne, Victoria, Australia